Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 133 to 140 of 140 entries
Sorted by: Best Match Show Resources per page
Naloxone-associated pulmonary edema following recreational opioid overdose: A case series.

The American journal of emergency medicine

Kummer RL, Kempainen RR, Olives TD, Leatherman JW, Prekker ME.
PMID: 34973491
Am J Emerg Med. 2021 Dec 17;53:41-43. doi: 10.1016/j.ajem.2021.12.030. Epub 2021 Dec 17.

OBJECTIVE: Describe a series of patients who developed naloxone-associated pulmonary edema after recreational opioid use.DESIGN: Single center retrospective case series of patients who developed pulmonary edema following the prehospital administration of naloxone.SETTING: Academic, urban safety-net hospital.PATIENTS: Adults with recreational...

Cite
Kummer RL, Kempainen RR, Olives TD, et al. Naloxone-associated pulmonary edema following recreational opioid overdose: A case series. Am J Emerg Med. 2021;53:41-43doi: 10.1016/j.ajem.2021.12.030.
Kummer, R. L., Kempainen, R. R., Olives, T. D., Leatherman, J. W., & Prekker, M. E. (2021). Naloxone-associated pulmonary edema following recreational opioid overdose: A case series. The American journal of emergency medicine, 5341-43. https://doi.org/10.1016/j.ajem.2021.12.030
Kummer, Rebecca L, et al. "Naloxone-associated pulmonary edema following recreational opioid overdose: A case series." The American journal of emergency medicine vol. 53 (2021): 41-43. doi: https://doi.org/10.1016/j.ajem.2021.12.030
Kummer RL, Kempainen RR, Olives TD, Leatherman JW, Prekker ME. Naloxone-associated pulmonary edema following recreational opioid overdose: A case series. Am J Emerg Med. 2021 Dec 17;53:41-43. doi: 10.1016/j.ajem.2021.12.030. Epub 2021 Dec 17. PMID: 34973491.
Copy Download .nbib Format: NLM
Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder.

Psychological medicine

Johnson EC, Kapoor M, Hatoum AS, Zhou H, Polimanti R, Wendt FR, Walters RK, Lai D, Kember RL, Hartz S, Meyers JL, Peterson RE, Ripke S, Bigdeli TB, Fanous AH, Pato CN, Pato MT, Goate AM, Kranzler HR, O'Donovan MC, Walters JTR, Gelernter J, Edenberg HJ, Agrawal A.
PMID: 34231451
Psychol Med. 2021 Jul 07;1-9. doi: 10.1017/S003329172100266X. Epub 2021 Jul 07.

BACKGROUND: Alcohol use disorder (AUD) and schizophrenia (SCZ) frequently co-occur, and large-scale genome-wide association studies (GWAS) have identified significant genetic correlations between these disorders.METHODS: We used the largest published GWAS for AUD (total cases = 77 822) and SCZ...

Cite
Johnson EC, Kapoor M, Hatoum AS, et al. Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder. Psychol Med. 2021;1-9doi: 10.1017/S003329172100266X.
Johnson, E. C., Kapoor, M., Hatoum, A. S., Zhou, H., Polimanti, R., Wendt, F. R., Walters, R. K., Lai, D., Kember, R. L., Hartz, S., Meyers, J. L., Peterson, R. E., Ripke, S., Bigdeli, T. B., Fanous, A. H., Pato, C. N., Pato, M. T., Goate, A. M., Kranzler, H. R., O'Donovan, M. C., Walters, J. T. R., Gelernter, J., Edenberg, H. J., & Agrawal, A. (2021). Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder. Psychological medicine, 1-9. https://doi.org/10.1017/S003329172100266X
Johnson, Emma C, et al. "Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder." Psychological medicine vol. (2021): 1-9. doi: https://doi.org/10.1017/S003329172100266X
Johnson EC, Kapoor M, Hatoum AS, Zhou H, Polimanti R, Wendt FR, Walters RK, Lai D, Kember RL, Hartz S, Meyers JL, Peterson RE, Ripke S, Bigdeli TB, Fanous AH, Pato CN, Pato MT, Goate AM, Kranzler HR, O'Donovan MC, Walters JTR, Gelernter J, Edenberg HJ, Agrawal A. Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder. Psychol Med. 2021 Jul 07;1-9. doi: 10.1017/S003329172100266X. Epub 2021 Jul 07. PMID: 34231451; PMCID: PMC8738774.
Copy Download .nbib Format: NLM
Oral Feeding in Infants After Congenital Diaphragmatic Hernia Repair While on Non-invasive Positive Pressure Ventilation: The Impact of a Dysphagia Provider-Led Protocol.

Dysphagia

Schwab ME, Crennan M, Burke S, Sang H, Klarich MK, Keller RL, Vu LT.
PMID: 34981254
Dysphagia. 2022 Jan 04; doi: 10.1007/s00455-021-10391-4. Epub 2022 Jan 04.

Infants with congenital diaphragmatic hernia (CDH) who require non-invasive positive pressure ventilation or high flow nasal cannula are at risk for aspiration and delayed initiation of oral feeding. We developed a dysphagia provider-led protocol that involved early consultation with...

Cite
Schwab ME, Crennan M, Burke S, et al. Oral Feeding in Infants After Congenital Diaphragmatic Hernia Repair While on Non-invasive Positive Pressure Ventilation: The Impact of a Dysphagia Provider-Led Protocol. Dysphagia. 2022;doi: 10.1007/s00455-021-10391-4.
Schwab, M. E., Crennan, M., Burke, S., Sang, H., Klarich, M. K., Keller, R. L., & Vu, L. T. (2022). Oral Feeding in Infants After Congenital Diaphragmatic Hernia Repair While on Non-invasive Positive Pressure Ventilation: The Impact of a Dysphagia Provider-Led Protocol. Dysphagia, . https://doi.org/10.1007/s00455-021-10391-4
Schwab, Marisa E, et al. "Oral Feeding in Infants After Congenital Diaphragmatic Hernia Repair While on Non-invasive Positive Pressure Ventilation: The Impact of a Dysphagia Provider-Led Protocol." Dysphagia vol. (2022). doi: https://doi.org/10.1007/s00455-021-10391-4
Schwab ME, Crennan M, Burke S, Sang H, Klarich MK, Keller RL, Vu LT. Oral Feeding in Infants After Congenital Diaphragmatic Hernia Repair While on Non-invasive Positive Pressure Ventilation: The Impact of a Dysphagia Provider-Led Protocol. Dysphagia. 2022 Jan 04; doi: 10.1007/s00455-021-10391-4. Epub 2022 Jan 04. PMID: 34981254.
Copy Download .nbib Format: NLM
Consensus statement for the perinatal management of patients with α thalassemia major.

Blood advances

MacKenzie TC, Amid A, Angastiniotis M, Butler C, Gilbert S, Gonzalez J, Keller RL, Kharbanda S, Kirby-Allen M, Koenig BA, Kyono W, Lal A, Lianoglou BR, Norton ME, Ogasawara KK, Panchalee T, Rosner M, Schwab M, Thompson A, Waye JS, Vichinsky E.
PMID: 34749399
Blood Adv. 2021 Dec 28;5(24):5636-5639. doi: 10.1182/bloodadvances.2021005916.

No abstract available.

Cite
MacKenzie TC, Amid A, Angastiniotis M, et al. Consensus statement for the perinatal management of patients with α thalassemia major. Blood Adv. 2021;5(24):5636-5639doi: 10.1182/bloodadvances.2021005916.
MacKenzie, T. C., Amid, A., Angastiniotis, M., Butler, C., Gilbert, S., Gonzalez, J., Keller, R. L., Kharbanda, S., Kirby-Allen, M., Koenig, B. A., Kyono, W., Lal, A., Lianoglou, B. R., Norton, M. E., Ogasawara, K. K., Panchalee, T., Rosner, M., Schwab, M., Thompson, A., Waye, J. S., & Vichinsky, E. (2021). Consensus statement for the perinatal management of patients with α thalassemia major. Blood advances, 5(24), 5636-5639. https://doi.org/10.1182/bloodadvances.2021005916
MacKenzie, Tippi C, et al. "Consensus statement for the perinatal management of patients with α thalassemia major." Blood advances vol. 5,24 (2021): 5636-5639. doi: https://doi.org/10.1182/bloodadvances.2021005916
MacKenzie TC, Amid A, Angastiniotis M, Butler C, Gilbert S, Gonzalez J, Keller RL, Kharbanda S, Kirby-Allen M, Koenig BA, Kyono W, Lal A, Lianoglou BR, Norton ME, Ogasawara KK, Panchalee T, Rosner M, Schwab M, Thompson A, Waye JS, Vichinsky E. Consensus statement for the perinatal management of patients with α thalassemia major. Blood Adv. 2021 Dec 28;5(24):5636-5639. doi: 10.1182/bloodadvances.2021005916. PMID: 34749399; PMCID: PMC8714716.
Copy Download .nbib Format: NLM
Characterisation of Pediatric Pulmonary Hypertensive Vascular Disease from the PPHNet Registry.

The European respiratory journal

Abman SH, Mullen MP, Sleeper LA, Austin ED, Rosenzweig EB, Kinsella JP, Ivy D, Hopper RK, Usha Raj J, Fineman J, Keller RL, Bates A, Krishnan US, Avitabile CM, Davidson A, Natter MD, Mandl KD.
PMID: 34140292
Eur Respir J. 2021 Jun 17; doi: 10.1183/13993003.03337-2020. Epub 2021 Jun 17.

BACKGROUND: There are limited data about the range of diseases, natural history, age-appropriate endpoints and optimal care for children with pulmonary hypertension (PH), including the need for developing high quality patient registries of children with diverse forms of PH...

Cite
Abman SH, Mullen MP, Sleeper LA, et al. Characterisation of Pediatric Pulmonary Hypertensive Vascular Disease from the PPHNet Registry. Eur Respir J. 2021;doi: 10.1183/13993003.03337-2020.
Abman, S. H., Mullen, M. P., Sleeper, L. A., Austin, E. D., Rosenzweig, E. B., Kinsella, J. P., Ivy, D., Hopper, R. K., Usha Raj, J., Fineman, J., Keller, R. L., Bates, A., Krishnan, U. S., Avitabile, C. M., Davidson, A., Natter, M. D., Mandl, K. D. (2021). Characterisation of Pediatric Pulmonary Hypertensive Vascular Disease from the PPHNet Registry. The European respiratory journal, . https://doi.org/10.1183/13993003.03337-2020
Abman, Steven H, et al. "Characterisation of Pediatric Pulmonary Hypertensive Vascular Disease from the PPHNet Registry." The European respiratory journal vol. (2021). doi: https://doi.org/10.1183/13993003.03337-2020
Abman SH, Mullen MP, Sleeper LA, Austin ED, Rosenzweig EB, Kinsella JP, Ivy D, Hopper RK, Usha Raj J, Fineman J, Keller RL, Bates A, Krishnan US, Avitabile CM, Davidson A, Natter MD, Mandl KD. Characterisation of Pediatric Pulmonary Hypertensive Vascular Disease from the PPHNet Registry. Eur Respir J. 2021 Jun 17; doi: 10.1183/13993003.03337-2020. Epub 2021 Jun 17. PMID: 34140292.
Copy Download .nbib Format: NLM
Hemodynamic optimization for neonates with neonatal encephalopathy caused by a hypoxic ischemic event: Physiological and therapeutic considerations.

Seminars in fetal & neonatal medicine

Rios DR, Lapointe A, Schmolzer GM, Mohammad K, VanMeurs KP, Keller RL, Sehgal A, Lakshminrusimha S, Giesinger RE.
PMID: 34481738
Semin Fetal Neonatal Med. 2021 Aug;26(4):101277. doi: 10.1016/j.siny.2021.101277. Epub 2021 Aug 12.

Neonatal encephalopathy due to a hypoxic-ischemic event is commonly associated with cardiac dysfunction and acute pulmonary hypertension; both therapeutic hypothermia and rewarming modify loading conditions and blood flow. The pathophysiological contributors to disease are complex with a high degree...

Cite
Rios DR, Lapointe A, Schmolzer GM, et al. Hemodynamic optimization for neonates with neonatal encephalopathy caused by a hypoxic ischemic event: Physiological and therapeutic considerations. Semin Fetal Neonatal Med. 2021;26(4):101277doi: 10.1016/j.siny.2021.101277.
Rios, D. R., Lapointe, A., Schmolzer, G. M., Mohammad, K., VanMeurs, K. P., Keller, R. L., Sehgal, A., Lakshminrusimha, S., Giesinger, R. E. (2021). Hemodynamic optimization for neonates with neonatal encephalopathy caused by a hypoxic ischemic event: Physiological and therapeutic considerations. Seminars in fetal & neonatal medicine, 26(4), 101277. https://doi.org/10.1016/j.siny.2021.101277
Rios, Danielle R, et al. "Hemodynamic optimization for neonates with neonatal encephalopathy caused by a hypoxic ischemic event: Physiological and therapeutic considerations." Seminars in fetal & neonatal medicine vol. 26,4 (2021): 101277. doi: https://doi.org/10.1016/j.siny.2021.101277
Rios DR, Lapointe A, Schmolzer GM, Mohammad K, VanMeurs KP, Keller RL, Sehgal A, Lakshminrusimha S, Giesinger RE. Hemodynamic optimization for neonates with neonatal encephalopathy caused by a hypoxic ischemic event: Physiological and therapeutic considerations. Semin Fetal Neonatal Med. 2021 Aug;26(4):101277. doi: 10.1016/j.siny.2021.101277. Epub 2021 Aug 12. PMID: 34481738.
Copy Download .nbib Format: NLM
Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder.

Psychological medicine

Johnson EC, Kapoor M, Hatoum AS, Zhou H, Polimanti R, Wendt FR, Walters RK, Lai D, Kember RL, Hartz S, Meyers JL, Peterson RE, Ripke S, Bigdeli TB, Fanous AH, Pato CN, Pato MT, Goate AM, Kranzler HR, O'Donovan MC, Walters JTR, Gelernter J, Edenberg HJ, Agrawal A.
PMID: 34231451
Psychol Med. 2021 Jul 07;1-9. doi: 10.1017/S003329172100266X. Epub 2021 Jul 07.

BACKGROUND: Alcohol use disorder (AUD) and schizophrenia (SCZ) frequently co-occur, and large-scale genome-wide association studies (GWAS) have identified significant genetic correlations between these disorders.METHODS: We used the largest published GWAS for AUD (total cases = 77 822) and SCZ...

Cite
Johnson EC, Kapoor M, Hatoum AS, et al. Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder. Psychol Med. 2021;1-9doi: 10.1017/S003329172100266X.
Johnson, E. C., Kapoor, M., Hatoum, A. S., Zhou, H., Polimanti, R., Wendt, F. R., Walters, R. K., Lai, D., Kember, R. L., Hartz, S., Meyers, J. L., Peterson, R. E., Ripke, S., Bigdeli, T. B., Fanous, A. H., Pato, C. N., Pato, M. T., Goate, A. M., Kranzler, H. R., O'Donovan, M. C., Walters, J. T. R., Gelernter, J., Edenberg, H. J., & Agrawal, A. (2021). Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder. Psychological medicine, 1-9. https://doi.org/10.1017/S003329172100266X
Johnson, Emma C, et al. "Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder." Psychological medicine vol. (2021): 1-9. doi: https://doi.org/10.1017/S003329172100266X
Johnson EC, Kapoor M, Hatoum AS, Zhou H, Polimanti R, Wendt FR, Walters RK, Lai D, Kember RL, Hartz S, Meyers JL, Peterson RE, Ripke S, Bigdeli TB, Fanous AH, Pato CN, Pato MT, Goate AM, Kranzler HR, O'Donovan MC, Walters JTR, Gelernter J, Edenberg HJ, Agrawal A. Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder. Psychol Med. 2021 Jul 07;1-9. doi: 10.1017/S003329172100266X. Epub 2021 Jul 07. PMID: 34231451.
Copy Download .nbib Format: NLM
Biotechnological synthesis of Pd/Ag and Pd/Au nanoparticles for enhanced Suzuki-Miyaura cross-coupling activity.

Microbial biotechnology

Kimber RL, Parmeggiani F, Neill TS, Merroun ML, Goodlet G, Powell NA, Turner NJ, Lloyd JR.
PMID: 33720526
Microb Biotechnol. 2021 Nov;14(6):2435-2447. doi: 10.1111/1751-7915.13762. Epub 2021 Mar 15.

Bimetallic nanoparticle catalysts have attracted considerable attention due to their unique chemical and physical properties. The ability of metal-reducing bacteria to produce highly catalytically active monometallic nanoparticles is well known; however, the properties and catalytic activity of bimetallic nanoparticles...

Cite
Kimber RL, Parmeggiani F, Neill TS, et al. Biotechnological synthesis of Pd/Ag and Pd/Au nanoparticles for enhanced Suzuki-Miyaura cross-coupling activity. Microb Biotechnol. 2021;14(6):2435-2447doi: 10.1111/1751-7915.13762.
Kimber, R. L., Parmeggiani, F., Neill, T. S., Merroun, M. L., Goodlet, G., Powell, N. A., Turner, N. J., & Lloyd, J. R. (2021). Biotechnological synthesis of Pd/Ag and Pd/Au nanoparticles for enhanced Suzuki-Miyaura cross-coupling activity. Microbial biotechnology, 14(6), 2435-2447. https://doi.org/10.1111/1751-7915.13762
Kimber, Richard L, et al. "Biotechnological synthesis of Pd/Ag and Pd/Au nanoparticles for enhanced Suzuki-Miyaura cross-coupling activity." Microbial biotechnology vol. 14,6 (2021): 2435-2447. doi: https://doi.org/10.1111/1751-7915.13762
Kimber RL, Parmeggiani F, Neill TS, Merroun ML, Goodlet G, Powell NA, Turner NJ, Lloyd JR. Biotechnological synthesis of Pd/Ag and Pd/Au nanoparticles for enhanced Suzuki-Miyaura cross-coupling activity. Microb Biotechnol. 2021 Nov;14(6):2435-2447. doi: 10.1111/1751-7915.13762. Epub 2021 Mar 15. PMID: 33720526; PMCID: PMC8601183.
Copy Download .nbib Format: NLM
Showing 133 to 140 of 140 entries